Cancer Research CR Mantle  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1337-1346, March 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chammas, R.
Right arrow Articles by Varki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chammas, R.
Right arrow Articles by Varki, A.
[Cancer Research 59, 1337-1346, March 15, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

De-N-acetyl-gangliosides in Humans

Unusual Subcellular Distribution of a Novel Tumor Antigen1

Roger Chammas2, Justin L. Sonnenburg, Nicki E. Watson, Tadashi Tai, Marilyn G. Farquhar, Nissi M. Varki and Ajit Varki3

Glycobiology Program and Cancer Center, Divisions of Hematology-Oncology and Cellular and Molecular Medicine, University of California San Diego, La Jolla, California 92093-0687 [R.C., J.L.S., N.E.W., M.G.F., N.M.V., A.V.], and Tokyo Metropolitan Institute, Tokyo 113, Japan [T. T.]

ABSTRACT

The disialoganglioside GD3 is a major antigen in human melanomas that can undergo 9-O-acetylation of the outer sialic acid (giving 9-OAc-GD3). Monoclonal antibody SGR37 detects a different modification of the GD3, de-N-acetylation of the 5-N-acetyl group (giving de-N-Ac-GD3). We found that conventional immunohistochemistry of the SGR37 antigen is limited by a reduction in reactivity upon fixation with aldehydes (which presumably react with the free amino group) or with organic reagents (which can extract glycolipids). We optimized conditions for detection of this antigen in unfixed frozen tissue sections and studied its distribution in human tissues and tumors. It is expressed at low levels in a few blood vessels, infiltrating mononuclear cells in the skin and colon, and at moderate levels in skin melanocytes. In contrast, the antigen accumulates at high levels in many melanomas and in some lymphomas but not in carcinomas. In positive melanomas, expression is sometimes more intense and widespread than that of GD3.

Both 9-O-acetylation and de-N-acetylation of GD3 seem to occur after its initial biosynthesis. Isotype-matched antibodies against GD3, 9-O-acetyl-GD3 and de-N-acetyl-GD3 were used to compare their subcellular localization and trafficking. 9-O-acetyl-GD3 colocalizes with GD3 predominantly on the cell surface and partly in lysosomal compartments. In contrast, de-N-acetyl-GD3 has a diffuse intracellular location. Adsorptive endocytosis of antibodies indicates that whereas GD3 remains predominantly on the cell surface, de-N-acetyl-GD3 is efficiently internalized into a compartment that is distinct from lysosomes. Rounding up of melanoma cells occurring during growth in culture is associated with relocation of the internal pool of de-N-acetyl-GD3 to the cell surface. Thus, a minor modification of the polar head group of a tumor-associated glycosphingolipid can markedly affect the subcellular localization and trafficking of the whole molecule. The high levels of the SGR37 antigen in melanomas and lymphomas, its selective endocytosis from the cell surface, and its relocation to the cell surface of rounded up cells suggest potential uses in diagnostic or therapeutic approaches to these diseases.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J.-W. Liu, P. Sun, Q. Yan, A. S. Paller, P. Gerami, N. Ho, N. Vashi, I. C. Le Poole, and X.-q. Wang
De-N-acetyl GM3 Promotes Melanoma Cell Migration and Invasion through Urokinase Plasminogen Activator Receptor Signaling-Dependent MMP-2 Activation
Cancer Res., November 15, 2009; 69(22): 8662 - 8669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. R. Moe, T. S. Bhandari, and B. A. Flitter
Vaccines Containing de-N-Acetyl Sialic Acid Elicit Antibodies Protective against Neisseria meningitidis Groups B and C
J. Immunol., May 15, 2009; 182(10): 6610 - 6617.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
I. Popa, A. Pons, C. Mariller, T. Tai, J.-P. Zanetta, L. Thomas, and J. Portoukalian
Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors
Glycobiology, April 1, 2007; 17(4): 367 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Satake, H. Y. Chen, and A. Varki
Genes Modulated by Expression of GD3 Synthase in Chinese Hamster Ovary Cells. EVIDENCE THAT THE Tis21 GENE IS INVOLVED IN THE INDUCTION OF GD3 9-O-ACETYLATION
J. Biol. Chem., February 28, 2003; 278(10): 7942 - 7948.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Y. Chen and A. Varki
O-acetylation of GD3: An Enigmatic Modification Regulating Apoptosis?
J. Exp. Med., December 16, 2002; 196(12): 1529 - 1533.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Sonnenburg, H. van Halbeek, and A. Varki
Characterization of the Acid Stability of Glycosidically Linked Neuraminic Acid. USE IN DETECTING DE-N-ACETYL-GANGLIOSIDES IN HUMAN MELANOMA
J. Biol. Chem., May 10, 2002; 277(20): 17502 - 17510.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. Kovacic, J. Müthing, and A. Marusic
Immunohistological and Flow Cytometric Analysis of Glycosphingolipid Expression in Mouse Lymphoid Tissues
J. Histochem. Cytochem., December 1, 2000; 48(12): 1677 - 1690.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Izawa, K. Kumamoto, C. Mitsuoka, A. Kanamori, K. Ohmori, H. Ishida, S. Nakamura, K. Kurata-Miura, K. Sasaki, T. Nishi, et al.
Expression of Sialyl 6-Sulfo Lewis X Is Inversely Correlated with Conventional Sialyl Lewis X Expression in Human Colorectal Cancer
Cancer Res., March 1, 2000; 60(5): 1410 - 1416.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.